Therapeutic approaches to Huntington disease: from the bench to the clinic
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic approaches to Huntington disease: from the bench to the clinic
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-21
DOI
10.1038/nrd.2018.133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences
- (2018) Tokuyuki Yoshida et al. GENES TO CELLS
- Artificial miRNAs Reduce Human Mutant Huntingtin Throughout the Striatum in a Transgenic Sheep Model of Huntington's Disease
- (2018) Edith L. Pfister et al. HUMAN GENE THERAPY
- The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice
- (2018) Juliette Hordeaux et al. MOLECULAR THERAPY
- Improved metrics for Huntington’s disease trials
- (2018) Kat Arney NATURE
- Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain
- (2018) Yasunori Matsuzaki et al. NEUROSCIENCE LETTERS
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
- (2017) Lauren M Byrne et al. LANCET NEUROLOGY
- CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
- (2017) Alex Mas Monteys et al. MOLECULAR THERAPY
- Neurotoxic reactive astrocytes are induced by activated microglia
- (2017) Shane A. Liddelow et al. NATURE
- The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease
- (2017) Daniel Ryskamp et al. NEUROBIOLOGY OF DISEASE
- Motor, cognitive, and functional declines contribute to a single progressive factor in early HD
- (2017) Scott A. Schobel et al. NEUROLOGY
- The CREST-E study of creatine for Huntington disease
- (2017) Steven M. Hersch et al. NEUROLOGY
- Phosphorylation of huntingtin at residue T3 is decreased in Huntington’s disease and modulates mutant huntingtin protein conformation
- (2017) Cristina Cariulo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Huntington’s Disease iPSC-Derived Brain Microvascular Endothelial Cells Reveal WNT-Mediated Angiogenic and Blood-Brain Barrier Deficits
- (2017) Ryan G. Lim et al. Cell Reports
- The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes
- (2017) Nicolas Merienne et al. Cell Reports
- Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis
- (2017) Paula Dietrich et al. PLoS Genetics
- Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
- (2017) Xiaohong Xu et al. Stem Cell Reports
- Preclinical Evaluation of a Lentiviral Vector for Huntingtin Silencing
- (2017) Karine Cambon et al. Molecular Therapy-Methods & Clinical Development
- Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial
- (2017) Harald Gelderblom et al. PLoS One
- The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain
- (2017) Nicole A. Datson et al. PLoS One
- Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease
- (2017) Alba Di Pardo et al. Scientific Reports
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
- (2017) Andreas Neueder et al. Scientific Reports
- Globus pallidus degeneration and clinicopathological features of Huntington disease
- (2016) Malvindar K. Singh-Bains et al. ANNALS OF NEUROLOGY
- In vivo proof-of-concept of removal of the huntingtin caspase cleavage motif-encoding exon 12 approach in the YAC128 mouse model of Huntington’s disease
- (2016) João Casaca-Carreira et al. BIOMEDICINE & PHARMACOTHERAPY
- The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America
- (2016) Chris Kay et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- A novel neurodevelopmental disorder associated with compound heterozygous variants in the huntingtin gene
- (2016) Lance H Rodan et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
- (2016) Vahri Beaumont et al. EXPERIMENTAL NEUROLOGY
- Treatment with the MAO-A inhibitor clorgyline elevates monoamine neurotransmitter levels and improves affective phenotypes in a mouse model of Huntington disease
- (2016) Marta Garcia-Miralles et al. EXPERIMENTAL NEUROLOGY
- Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons
- (2016) Dagmar E. Ehrnhoefer et al. EXPERIMENTAL NEUROLOGY
- Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease
- (2016) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Serine 421 regulates mutant huntingtin toxicity and clearance in mice
- (2016) Ian H. Kratter et al. JOURNAL OF CLINICAL INVESTIGATION
- Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
- (2016) Lucianne Dobson et al. JOURNAL OF NEUROCHEMISTRY
- A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
- (2016) Jose Luis López-Sendón Moreno et al. JOURNAL OF NEUROLOGY
- Functional Indicators of Glutamate Transport in Single Striatal Astrocytes and the Influence of Kir4.1 in Normal and Huntington Mice
- (2016) Anton Dvorzhak et al. JOURNAL OF NEUROSCIENCE
- Mutant Huntingtin Impairs BDNF Release from Astrocytes by Disrupting Conversion of Rab3a-GTP into Rab3a-GDP
- (2016) Y. Hong et al. JOURNAL OF NEUROSCIENCE
- Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice
- (2016) R. Jiang et al. JOURNAL OF NEUROSCIENCE
- Symptom heterogeneity in Huntington's disease correlates with neuronal degeneration in the cerebral cortex
- (2016) Nasim F. Mehrabi et al. NEUROBIOLOGY OF DISEASE
- A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
- (2016) Andrew McGarry et al. NEUROLOGY
- Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
- (2016) Vahri Beaumont et al. NEURON
- Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis
- (2016) Guohao Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deutetrabenazine—Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease
- (2016) Ralf Reilmann JAMA Neurology
- Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease
- (2016) Piotr Hadaczek et al. Molecular Therapy-Methods & Clinical Development
- Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
- (2016) Marta Garcia-Miralles et al. Scientific Reports
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
- (2015) Sigurd D. Süssmuth et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease
- (2015) Karl Kieburtz et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pridopidine, a dopamine stabilizer, improves motor performance and shows neuroprotective effects in Huntington disease R6/2 mouse model
- (2015) Ferdinando Squitieri et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington’s disease patients
- (2015) Edward J. Wild et al. JOURNAL OF CLINICAL INVESTIGATION
- Deep brain stimulation of the internal pallidum in Huntington’s disease patients: clinical outcome and neuronal firing patterns
- (2015) Cécile Delorme et al. JOURNAL OF NEUROLOGY
- Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
- (2015) LANCET NEUROLOGY
- Nonclinical Safety Evaluation of VX15/2503, a Humanized IgG4 Anti-SEMA4D Antibody
- (2015) J. E. Leonard et al. MOLECULAR CANCER THERAPEUTICS
- A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease
- (2015) Ralf Reilmann et al. MOVEMENT DISORDERS
- SEMA4D compromises blood–brain barrier, activates microglia, and inhibits remyelination in neurodegenerative disease
- (2015) Ernest S. Smith et al. NEUROBIOLOGY OF DISEASE
- Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease
- (2015) Amber L. Southwell et al. NEUROBIOLOGY OF DISEASE
- Mutant Huntingtin Downregulates Myelin Regulatory Factor-Mediated Myelin Gene Expression and Affects Mature Oligodendrocytes
- (2015) Brenda Huang et al. NEURON
- RAN Translation in Huntington Disease
- (2015) Monica Bañez-Coronel et al. NEURON
- Pallidal deep brain stimulation in Huntington's disease
- (2015) S. Zittel et al. PARKINSONISM & RELATED DISORDERS
- Ultrasensitive measurement of huntingtin protein in cerebrospinal fluid demonstrates increase with Huntington disease stage and decrease following brain huntingtin suppression
- (2015) Amber L. Southwell et al. Scientific Reports
- Feasibility of Virtual Research Visits in Fox Trial Finder
- (2015) E. Ray Dorsey et al. Journal of Parkinsons Disease
- Novel Methods and Technologies for 21st-Century Clinical Trials
- (2015) E. Ray Dorsey et al. JAMA Neurology
- A Prospective Pilot Trial for Pallidal Deep Brain Stimulation in Huntington’s Disease
- (2015) Lars Wojtecki et al. Frontiers in Neurology
- Cortical interneuron loss and symptom heterogeneity in Huntington disease
- (2014) Eric H. Kim et al. ANNALS OF NEUROLOGY
- Silencing Mutant Huntingtin by Adeno-Associated Virus-Mediated RNA Interference Ameliorates Disease Manifestations in the YAC128 Mouse Model of Huntington's Disease
- (2014) Lisa M. Stanek et al. HUMAN GENE THERAPY
- Identification of a post-translationally myristoylated autophagy-inducing domain released by caspase cleavage of Huntingtin
- (2014) D. D. O. Martin et al. HUMAN MOLECULAR GENETICS
- Deep brain stimulation for Huntington's disease: long-term results of a prospective open-label study
- (2014) Victoria Gonzalez et al. JOURNAL OF NEUROSURGERY
- Inhibition of Excessive Monoamine Oxidase A/B Activity Protects Against Stress-induced Neuronal Death in Huntington Disease
- (2014) Jolene Ooi et al. MOLECULAR NEUROBIOLOGY
- In Vivo Evaluation of Candidate Allele-specific Mutant Huntingtin Gene Silencing Antisense Oligonucleotides
- (2014) Amber L Southwell et al. MOLECULAR THERAPY
- Intrajugular Vein Delivery of AAV9-RNAi Prevents Neuropathological Changes and Weight Loss in Huntington's Disease Mice
- (2014) Brett D Dufour et al. MOLECULAR THERAPY
- Prospects for neuroprotective therapies in prodromal Huntington's disease
- (2014) Abhishek Chandra et al. MOVEMENT DISORDERS
- Diagnostic criteria for Huntington's disease based on natural history
- (2014) Ralf Reilmann et al. MOVEMENT DISORDERS
- A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study
- (2014) Caroline M. Tanner et al. MOVEMENT DISORDERS
- Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease
- (2014) Nan Wang et al. NATURE MEDICINE
- Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors
- (2014) Andrea Crotti et al. NATURE NEUROSCIENCE
- Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice
- (2014) Xiaoping Tong et al. NATURE NEUROSCIENCE
- Huntington disease: natural history, biomarkers and prospects for therapeutics
- (2014) Christopher A. Ross et al. Nature Reviews Neurology
- PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease
- (2014) H. D. Rosas et al. NEUROLOGY
- Phosphorylation of Mutant Huntingtin at Serine 116 Modulates Neuronal Toxicity
- (2014) Erin E. Watkin et al. PLoS One
- Allele-Specific Suppression of Mutant Huntingtin Using Antisense Oligonucleotides: Providing a Therapeutic Option for All Huntington Disease Patients
- (2014) Niels H. Skotte et al. PLoS One
- Preventing Formation of Toxic N-Terminal Huntingtin Fragments Through Antisense Oligonucleotide-Mediated Protein Modification
- (2014) Melvin M. Evers et al. Nucleic Acid Therapeutics
- The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease
- (2014) David S. Russell et al. JAMA Neurology
- Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
- (2014) Manoj Kumar Mishra et al. Annals of Clinical and Translational Neurology
- Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes
- (2013) Fiona K Baine et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model
- (2013) Albert Giralt et al. HIPPOCAMPUS
- The huntingtin N17 domain is a multifunctional CRM1 and Ran-dependent nuclear and cilial export signal
- (2013) T. Maiuri et al. HUMAN MOLECULAR GENETICS
- Live cell imaging and biophotonic methods reveal two types of mutant huntingtin inclusions
- (2013) Nicholas S. Caron et al. HUMAN MOLECULAR GENETICS
- Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records
- (2013) Stephen JW Evans et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
- (2013) Sarah J Tabrizi et al. LANCET NEUROLOGY
- A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease
- (2013) MOVEMENT DISORDERS
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- Ataxin-3 protein modification as a treatment strategy for spinocerebellar ataxia type 3: Removal of the CAG containing exon
- (2013) Melvin M. Evers et al. NEUROBIOLOGY OF DISEASE
- Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice
- (2013) Alejandro Dau et al. NEUROBIOLOGY OF DISEASE
- PET imaging shows loss of striatal PDE10A in patients with Huntington disease
- (2013) R. Ahmad et al. NEUROLOGY
- One-year safety and tolerability profile of pridopidine in patients with Huntington disease
- (2013) F. Squitieri et al. NEUROLOGY
- Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin
- (2013) Nicholas Stephane Caron et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease
- (2013) K. Sathasivam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Sigma-1 receptor agonist PRE084 is protective against mutant huntingtin-induced cell degeneration: involvement of calpastatin and the NF-κB pathway
- (2013) A Hyrskyluoto et al. Cell Death & Disease
- Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress
- (2013) Julia Leitman et al. Nature Communications
- Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
- (2012) Wolfgang Brück et al. ACTA NEUROPATHOLOGICA
- Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum
- (2012) Richard Grondin et al. BRAIN
- Axonal transport of adeno-associated viral vectors is serotype-dependent
- (2012) E A Salegio et al. GENE THERAPY
- Mutant huntingtin impairs immune cell migration in Huntington disease
- (2012) Wanda Kwan et al. JOURNAL OF CLINICAL INVESTIGATION
- Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
- (2012) Rina Aharoni et al. JOURNAL OF NEUROIMMUNOLOGY
- The dopamine stabilizers ACR16 and (−)-OSU6162 display nanomolar affinities at the σ-1 receptor
- (2012) K Sahlholm et al. MOLECULAR PSYCHIATRY
- Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease
- (2012) Zhihong Guo et al. MOVEMENT DISORDERS
- Sustained Therapeutic Reversal of Huntington's Disease by Transient Repression of Huntingtin Synthesis
- (2012) Holly B. Kordasiewicz et al. NEURON
- Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice
- (2012) A. Di Pardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic zinc finger repressors reduce mutant huntingtin expression in the brain of R6/2 mice
- (2012) M. Garriga-Canut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Antisense oligonucleotide therapeutics for inherited neurodegenerative diseases
- (2012) Amber L. Southwell et al. TRENDS IN MOLECULAR MEDICINE
- A Pathogenic Mechanism in Huntington's Disease Involves Small CAG-Repeated RNAs with Neurotoxic Activity
- (2012) Mónica Bañez-Coronel et al. PLoS Genetics
- Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
- (2011) Jan Thöne et al. AMERICAN JOURNAL OF PATHOLOGY
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
- (2011) Daniel Zwilling et al. CELL
- The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's Disease
- (2011) Susanna Campesan et al. CURRENT BIOLOGY
- HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia
- (2011) Simon C Warby et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Protein aggregates in Huntington's disease
- (2011) Montserrat Arrasate et al. EXPERIMENTAL NEUROLOGY
- Mutant huntingtin causes defective actin remodeling during stress: defining a new role for transglutaminase 2 in neurodegenerative disease
- (2011) Lise Munsie et al. HUMAN MOLECULAR GENETICS
- Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial
- (2011) Justo Garcia de Yebenes et al. LANCET NEUROLOGY
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
- (2011) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Mass Spectrometric Identification of Novel Lysine Acetylation Sites in Huntingtin
- (2011) Xin Cong et al. MOLECULAR & CELLULAR PROTEOMICS
- Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin
- (2011) Jeffrey B Carroll et al. MOLECULAR THERAPY
- Preclinical Safety of RNAi-Mediated HTT Suppression in the Rhesus Macaque as a Potential Therapy for Huntington's Disease
- (2011) Jodi L McBride et al. MOLECULAR THERAPY
- Kinase inhibitors modulate huntingtin cell localization and toxicity
- (2011) Randy Singh Atwal et al. Nature Chemical Biology
- Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity
- (2011) Wenjun Song et al. NATURE MEDICINE
- Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development
- (2011) Dagmar E. Ehrnhoefer et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide
- (2011) Melvin M. Evers et al. PLoS One
- Allele-Selective Inhibition of MutantHuntingtinExpression with Antisense Oligonucleotides Targeting the Expanded CAG Repeat
- (2010) Keith T. Gagnon et al. BIOCHEMISTRY
- Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington’s disease
- (2010) Doris C. V. Thu et al. BRAIN
- Allele-Selective Inhibition of Huntingtin Expression by Switching to an miRNA-like RNAi Mechanism
- (2010) Jiaxin Hu et al. CHEMISTRY & BIOLOGY
- In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects
- (2010) M. Faideau et al. HUMAN MOLECULAR GENETICS
- Longitudinal change in regional brain volumes in prodromal Huntington disease
- (2010) E. H. Aylward et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cleavage at the 586 Amino Acid Caspase-6 Site in Mutant huntingtin Influences Caspase-6 Activation In Vivo
- (2010) R. K. Graham et al. JOURNAL OF NEUROSCIENCE
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
- (2010) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Location, Location, Location: Contrasting Roles of Synaptic and Extrasynaptic NMDA Receptors in Huntington's Disease
- (2010) Michael S. Levine et al. NEURON
- Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
- (2010) Austen J. Milnerwood et al. NEURON
- Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
- (2010) Carmela Giampà et al. PLoS One
- Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases
- (2009) Xiao-xia Dong et al. ACTA PHARMACOLOGICA SINICA
- CAG Expansion in the Huntington Disease Gene Is Associated with a Specific and Targetable Predisposing Haplogroup
- (2009) Simon C. Warby et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Sustained effects of nonallele-specificHuntingtinsilencing
- (2009) Valérie Drouet et al. ANNALS OF NEUROLOGY
- Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin
- (2009) M. A. Pouladi et al. BRAIN
- Acetylation Targets Mutant Huntingtin to Autophagosomes for Degradation
- (2009) Hyunkyung Jeong et al. CELL
- Five siRNAs Targeting Three SNPs May Provide Therapy for Three-Quarters of Huntington's Disease Patients
- (2009) Edith L. Pfister et al. CURRENT BIOLOGY
- The dopaminergic stabilizers pridopidine (ACR16) and (−)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties
- (2009) Tino Dyhring et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Huntingtin facilitates polycomb repressive complex 2
- (2009) Ihn Sik Seong et al. HUMAN MOLECULAR GENETICS
- Phosphorylation of Threonine 3
- (2009) Charity T. Aiken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome
- (2009) Leslie Michels Thompson et al. JOURNAL OF CELL BIOLOGY
- Roles of Sema4D-Plexin-B1 Interactions in the Central Nervous System for Pathogenesis of Experimental Autoimmune Encephalomyelitis
- (2009) T. Okuno et al. JOURNAL OF IMMUNOLOGY
- Interaction of Postsynaptic Density Protein-95 with NMDA Receptors Influences Excitotoxicity in the Yeast Artificial Chromosome Mouse Model of Huntington's Disease
- (2009) J. Fan et al. JOURNAL OF NEUROSCIENCE
- Beyond the brain: widespread pathology in Huntington's disease
- (2009) Jorien MM van der Burg et al. LANCET NEUROLOGY
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- Mutant Huntingtin Impairs Vesicle Formation from Recycling Endosomes by Interfering with Rab11 Activity
- (2009) X. Li et al. MOLECULAR AND CELLULAR BIOLOGY
- Nonallele-specific Silencing of Mutant and Wild-type Huntingtin Demonstrates Therapeutic Efficacy in Huntington's Disease Mice
- (2009) Ryan L Boudreau et al. MOLECULAR THERAPY
- Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs
- (2009) Jiaxin Hu et al. NATURE BIOTECHNOLOGY
- Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
- (2009) Shu-ichi Okamoto et al. NATURE MEDICINE
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD Mice
- (2009) Xiaofeng Gu et al. NEURON
- Distinct neuroinflammatory profile in post-mortem human Huntingtonʼs disease
- (2009) Aurelio Silvestroni et al. NEUROREPORT
- Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms
- (2009) Jennifer Bradford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Zinc-finger directed double-strand breaks within CAG repeat tracts promote repeat instability in human cells
- (2009) D. Mittelman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity
- (2008) H. D. Rosas et al. BRAIN
- Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors
- (2008) F. Léveillé et al. FASEB JOURNAL
- Identification and Allele-Specific Silencing of the Mutant Huntingtin Allele in Huntington's Disease Patient-Derived Fibroblasts
- (2008) P.H.J. van Bilsen et al. HUMAN GENE THERAPY
- A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease
- (2008) Maria Björkqvist et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Allele-specific silencing of mutant Huntington’s disease gene
- (2008) Yu Zhang et al. JOURNAL OF NEUROCHEMISTRY
- N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking
- (2008) A. L. Orr et al. JOURNAL OF NEUROSCIENCE
- Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle
- (2008) M. Penaud-Budloo et al. JOURNAL OF VIROLOGY
- AAV Vector–mediated RNAi of Mutant Huntingtin Expression Is Neuroprotective in a Novel Genetic Rat Model of Huntington's Disease
- (2008) Nicholas R Franich et al. MOLECULAR THERAPY
- Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results
- (2008) Christopher G. Goetz et al. MOVEMENT DISORDERS
- Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses
- (2008) Sofia Papadia et al. NATURE NEUROSCIENCE
- Symptomatic treatment of Huntington disease
- (2008) Octavian R. Adam et al. Neurotherapeutics
- Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi
- (2008) J. L. McBride et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now